Biote Corp. (BTMD) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Biote Corp. (BTMD:NASDAQ), powered by AI.

Current Price
$2.19
Sector
Healthcare
What is the Biote Corp. stock price forecast?

Biote Corp. is currently trading at $2.19. View real-time AI analysis on Alpha Lenz.

What is Biote Corp. insider trading activity?

View the latest insider trading data for Biote Corp. on Alpha Lenz.

What is Biote Corp.'s P/E ratio?

View Biote Corp.'s valuation metrics on Alpha Lenz.

Biote Corp.

NASDAQ · BTMD
$2.19-0.06(-2.67%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Biote Corp.'s future dividend policy...
Alpha Chat Insight

Biote Corp.'s ROE is -32.9%. Explore profitability and growth together.

Ask for details

Company Overview

Biote Corp. operates in the healthcare sector as a life sciences company specializing in bioidentical hormone replacement therapy. The primary function of Biote Corp. is to provide comprehensive hormone optimization therapies designed to improve the quality of life for individuals experiencing hormonal imbalances and deficiencies. This is achieved through its innovative pellet therapy, a significant part of the hormone replacement treatment options available. Biote stands out in its field by offering not just the hormone therapies but also education for healthcare providers to ensure effective deployment of its solutions. By focusing on personalized health solutions, Biote Corp. impacts the healthcare industry, particularly in sectors related to wellness, anti-aging, and preventive medicine. Its approach aligns with the growing emphasis on personalized medicine, where treatment plans are tailored to individual patient needs. In the financial market, Biote Corp. plays a crucial role in expanding the portfolio of companies in the biotechnology and healthcare space, offering potential growth stories driven by the increasing demand for innovative health solutions. The company's efforts in hormone therapy contribute significantly to wellness and quality of life standards.

CEOMr. Bret Christensen
SectorHealthcare
IndustryMedical Care Facilities
Employees217

Company Statistics

FY 2025

Profile

N/AMarket Cap
$192.22MRevenue
0.00Shares Out
217Employees

Margins

71.46%Gross
20.39%EBITDA
18.50%Operating
19.55%Pre-Tax
16.44%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

5.23%Rev 3Yr
10.52%Rev 5Yr
N/AOp Inc 3Yr
2.27%Op Inc 5Yr
187.91%Net Inc 3Yr
1.62%Net Inc 5Yr

Returns

27.48%ROA
-32.89%ROE
42.22%ROIC

Financial Health

$24.12MCash & Cash Equivalents
$133.89MNet Debt
-313.53%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Biote Corp. (ticker: BTMD) is a company listed on NASDAQ in the Healthcare sector (Medical Care Facilities). It has approximately 217 employees.

The current price is $2.19 with a P/E ratio of -x and P/B of -x.

ROE is -32.89% and operating margin is 18.50%. Annual revenue is $192M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Biote Corp. (BTMD) Stock Forecast 2026 $2.19 — Price, Financials & Analyst Targets | Alpha Lenz